Related Experiment Video
Updated: Oct 6, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Recent Developments in Clinical Plasma Proteomics-Applied to Cardiovascular Research
Nicolai Bjødstrup Palstrøm1, Rune Matthiesen2, Lars Melholt Rasmussen1
1Centre for Clinical Proteomics, Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, 5000 Odense, Denmark.
The human plasma proteome offers insights into cardiovascular health. Recent technological advancements are enabling the discovery of novel plasma biomarkers for diagnosing and managing complex cardiovascular diseases.
Area of Science:
- Cardiovascular Medicine
- Proteomics
Background:
- The human plasma proteome reflects the cardiovascular system's physiological state.
- Current plasma biomarkers are limited, failing to address prevalent cardiovascular diseases like heart failure and abdominal aortic aneurysm.
- Novel biomarkers are urgently needed for diagnosing and stratifying these conditions.
Purpose of the Study:
- To provide an overview of recent technological advancements in human plasma proteomic analysis.
- To highlight the applications of these technologies in cardiovascular medicine.
- To facilitate the discovery of novel cardiovascular disease biomarkers.
Main Methods:
- Review of recent achievements in technologies for analyzing the human plasma proteome.
- Discussion of the analytical complexity in biomarker discovery.
- Exploration of technological solutions addressing proteomic complexity.
Main Results:
- Recent technological progress has overcome challenges in analyzing the complex human plasma proteome.
- These advancements enhance the potential for discovering novel plasma biomarkers.
- The article details specific technologies applicable to cardiovascular medicine.
Conclusions:
- Technological advancements in plasma proteomic analysis are crucial for addressing unmet needs in cardiovascular disease diagnosis and monitoring.
- These innovations pave the way for identifying new biomarkers for conditions like heart failure and abdominal aortic aneurysm.
- Further application of these technologies promises to improve cardiovascular patient care.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...

